Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
azacitidine (vidaza) (1 trial)
chidamide (2 trials)
sintilimab (1 trial)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Trials (2 total)
Trial APIs (3 total)